What is the recommended management approach for a scar site pregnancy?

Management of Cesarean Scar Pregnancy

Immediate Recommendation

Expectant management is NOT recommended due to the extremely high risk (approaching 100%) of developing placenta accreta spectrum disorders, and active treatment should be initiated as early as possible after diagnosis confirmation. 1, 2

---

Diagnostic Confirmation

Before initiating treatment, confirm the diagnosis with:

• Transvaginal ultrasound showing gestational sac embedded in the cesarean scar, empty uterine cavity and cervical canal, and thin/absent myometrium between the sac and bladder 2
• MRI without contrast if ultrasound findings are inconclusive (sensitivity 94.4%, specificity 84.0%) 2
• Refer to centers with expertise in imaging and diagnosis if available 2

---

Treatment Algorithm Based on Patient Factors

For Patients NOT Desiring Future Fertility

Hysterectomy is the definitive treatment and should be strongly considered, particularly in patients with multiple prior cesarean deliveries or advanced gestational age 3

• Eliminates all risks of hemorrhage, uterine rupture, and need for additional interventions 3
• Most appropriate for patients with completed childbearing 3

For Patients Desiring Future Fertility

Treatment effectiveness decreases with advancing gestational age, so treat as early as possible after diagnosis 4

First-Line Treatment Options (in order of effectiveness):

1. Suction evacuation (dilation and curettage): Success rate 91.5% (95% CI: 87.8-95.2%) 4

   • Most effective surgical option for fertility preservation 4
   • Should be performed by experienced operators due to hemorrhage risk 4

2. Balloon management: Success rate comparable to suction evacuation at >90% 4

   • Alternative surgical approach with high effectiveness 4

3. Surgical excision: Success rate >90% when performed early 4

   • Minimally invasive approach should be standard of care 3
   • Overall surgical treatment successful in 91.5% (95% CI: 88.4-94.5%) with complications in only 9.3% 4

4. Systemic methotrexate: Success rate only 59.4% (95% CI: 48.4-70.4%) 4

   • Should NOT be recommended as first-line treatment due to substantial failure risk and higher complication rates 4
   • May be considered in highly selected cases with very early diagnosis and strong patient preference 5, 6
   • Typical dosing: 1 mg/kg intramuscularly, may require multiple doses 3

5. Local medical treatment (potassium chloride or methotrexate injection): Less efficient than surgical options with higher complication rates 4

   • Not recommended as first-line 4

---

Critical Management Considerations

Timing of Intervention

• Treat before 12+6 weeks gestation whenever possible 4
• Effectiveness of ALL treatment modalities decreases significantly with advancing gestational age 4
• Early diagnosis and management remain the mainstay for successful outcomes 5

If Patient Chooses to Continue Pregnancy Despite Counseling

• Cesarean delivery is mandatory 1
• Anticipate placenta accreta spectrum with near 100% risk 1, 2
• Requires multidisciplinary team including maternal-fetal medicine, gynecologic oncology/complex pelvic surgery, anesthesia, and blood bank 1
• After 20 weeks: use left uterine displacement, maintain maternal oxygenation, optimize uteroplacental perfusion 1
• Continuous fetal heart rate monitoring if fetus is viable 1

Monitoring After Treatment

• Serial β-hCG levels until undetectable 5
• Mean time to β-hCG resolution does not differ significantly between treatment modalities 5
• Ultrasound follow-up to confirm complete resolution 5

---

Common Pitfalls to Avoid

• Do not misdiagnose as cervical pregnancy or spontaneous abortion - maintain high clinical suspicion in any woman with prior cesarean delivery presenting with early pregnancy symptoms or bleeding 2
• Do not use systemic methotrexate as first-line when surgical options are available - it has the highest failure rate (40.6%) and complication risk 4
• Do not delay treatment - effectiveness decreases substantially with each advancing week of gestation 4
• Do not offer expectant management - the risk of life-threatening hemorrhage and uterine rupture is too high 1, 4

---

Second-Line Treatment

Approximately 25.92% of patients require additional treatment after first-line therapy fails 5

• Surgical intervention (suction evacuation or excision) should be used for failed medical management 5
• Uterine artery embolization combined with systemic methotrexate is an alternative option 5
• Hysterectomy remains the definitive option if hemorrhage occurs or other treatments fail 3